Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,726,000 | 12,599,000 | 10,875,000 | 10,346,000 | 7,890,000 |
| Marketable Securities | 776,000 | 1,004,000 | 907,000 | 513,000 | 204,000 |
| Receivables | 11,422,000 | 11,415,000 | 10,801,000 | 10,747,000 | 11,026,000 |
| Inventories | 2,758,000 | 2,737,000 | 2,666,000 | 2,557,000 | 3,332,000 |
| Other current assets | 4,948,000 | 5,467,000 | 5,534,000 | 5,617,000 | 5,623,000 |
| TOTAL | $35,630,000 | $33,222,000 | $30,783,000 | $29,780,000 | $28,075,000 |
| Non-Current Assets | |||||
| PPE Net | 7,349,000 | 7,373,000 | 7,213,000 | 7,136,000 | 6,903,000 |
| Investments And Advances | 406,000 | 346,000 | 344,000 | 320,000 | 324,000 |
| Intangibles | 42,210,000 | 43,154,000 | 44,223,000 | 45,026,000 | 48,715,000 |
| Other Non-Current Assets | 11,293,000 | 10,583,000 | 9,863,000 | 10,341,000 | 9,653,000 |
| TOTAL | $61,258,000 | $61,456,000 | $61,643,000 | $62,823,000 | $65,595,000 |
| Total Assets | $96,889,000 | $94,676,000 | $92,427,000 | $92,603,000 | $93,670,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,509,000 | 4,715,000 | 3,554,000 | 2,046,000 | 1,078,000 |
| Accounts payable and accrued liabilities | 4,288,000 | 5,427,000 | 4,002,000 | 3,602,000 | 3,469,000 |
| Other current liabilities | 19,339,000 | 17,386,000 | 16,514,000 | 18,126,000 | 18,091,000 |
| TOTAL | $28,136,000 | $27,528,000 | $24,070,000 | $23,774,000 | $22,638,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44,469,000 | 44,470,000 | 46,157,000 | 47,603,000 | 48,674,000 |
| Other Non-Current Liabilities | 5,465,000 | 4,940,000 | 4,471,000 | 4,465,000 | 4,724,000 |
| TOTAL | $50,153,000 | $49,659,000 | $50,910,000 | $52,441,000 | $53,832,000 |
| Total Liabilities | $78,289,000 | $77,187,000 | $74,979,000 | $76,215,000 | $76,470,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,035,753 | 2,035,436 | 2,035,081 | 2,029,312 | 2,028,177 |
| Common Shares | 292,000 | 292,000 | 292,000 | 292,000 | 292,000 |
| Retained earnings | 17,093,000 | 16,154,000 | 16,106,000 | 14,912,000 | 16,097,000 |
| Other shareholders' equity | -1,464,000 | -1,501,000 | -1,364,000 | -1,185,000 | -1,410,000 |
| TOTAL | $18,600,000 | $17,489,000 | $17,448,000 | $16,388,000 | $17,200,000 |
| Total Liabilities And Equity | $96,889,000 | $94,676,000 | $92,427,000 | $92,603,000 | $93,670,000 |